Cited by 28Barrier Structure and Function StudiesNeurological Disease Mechanisms and TreatmentsRenin-Angiotensin System Studies

Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior

Open access
Huber, Gianna, Ogrodnik, Mikolaj, Wenzel, Jan, Stölting, Ines, Huber, Lukas, Will, Olga, Peschke, Eva, Matschl, Urte +4 more·2021·Journal of Cerebral Blood Flow & Metabolism

Abstract

Angiotensin II receptor blockers (telmisartan) prevent rodents from diet-induced obesity and improve their metabolic status. Hyperglycemia and obesity are associated with reduced cerebral blood flow and neurovascular uncoupling which may lead to behavioral deficits. We wanted to know whether a treatment with telmisartan prevents these changes in obesity. We put young mice on high-fat diet and simultaneously treated them with telmisartan. At the end of treatment, we performed laser speckle imaging and magnetic resonance imaging to assess the effect on neurovascular coupling and cerebral blood flow. Different behavioral tests were used to investigate cognitive function. Mice developed diet-induced obesity and after 16, not 8 weeks of high-fat diet, however, the response to whisker pad stimulation was about 30% lower in obese compared to lean mice. Simultaneous telmisartan treatment increased the response again by 10% compared to obese mice. Moreover, telmisartan treatment normalized high-fat diet-induced reduction of cerebral blood flow and prevented a diet-induced anxiety-like behavior. In addition to that, telmisartan affects cellular senescence and string vessel formation in obesity. We conclude, that telmisartan protects against neurovascular unit impairments in a diet-induced obesity setting and may play a role in preventing obesity related cognitive deficits in Alzheimer’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0271678x211003497

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The reductions in nerve endings and network complexity suggest a potential mechanism for sensory alterations in obesity, including reduced sensitivity to whisker stimulation and aberrant sensory and pain processing previously observed in obese mice.

    “The reductions in nerve endings and network complexity suggest a potential mechanism for sensory alterations in obesity, including the reduced sensitivity to whisker stimulation observed by us and the aberrant sensory and pain processing previously observed in obese mice30–32.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huber, G., Ogrodnik, M., Wenzel, J., Stölting, I., Huber, L., Will, O., Peschke, E., Matschl, U., Hövener, J.-B., Schwaninger, M., Jurk, D., & Raasch, W.
Affiliations
  • German Centre for Cardiovascular Research (DE)
  • Mayo Clinic (US)
  • University of Lübeck (DE)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Leibniz Institute of Virology (LIV) (DE)
Corresponding author
Raasch, Walter
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2021-03-17
Volume
41
Issue
9
Pages
2356-2369
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W3137729977
Cited by
28
References
57
Citations by year
2026: 5 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 2
FWCI
1.60
Type
journal article
Language
en
Open access
Locations
  • Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (R01AG068182)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
telmisartan, angiotensin receptor blockers, high-fat diet, diet-induced obesity, neurovascular coupling, cerebral blood flow, neurovascular uncoupling, anxiety-like behavior, cellular senescence, Alzheimer's disease
MeSH terms
Telmisartan, Animals, Anxiety, Disease Models, Animal, Male, Obesity, Angiotensin II Type 1 Receptor Blockers, Mice, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review